Logo image of HCWB

HCW BIOLOGICS INC (HCWB) Stock Price, Quote, News and Overview

NASDAQ:HCWB - Nasdaq - US40423R2040 - Common Stock - Currency: USD

5.49  -0.09 (-1.61%)

After market: 5.35 -0.14 (-2.55%)

HCWB Quote, Performance and Key Statistics

HCW BIOLOGICS INC

NASDAQ:HCWB (6/10/2025, 8:00:01 PM)

After market: 5.35 -0.14 (-2.55%)

5.49

-0.09 (-1.61%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High100.8
52 Week Low5
Market Cap10.43M
Shares1.90M
Float1.32M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO07-20 2021-07-20


HCWB short term performance overview.The bars show the price performance of HCWB in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40 -60

HCWB long term performance overview.The bars show the price performance of HCWB in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of HCWB is 5.49 USD. In the past month the price increased by 5.37%. In the past year, price decreased by -87.75%.

HCW BIOLOGICS INC / HCWB Daily stock chart

HCWB Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 18.45 334.73B
AMGN AMGEN INC 14.13 157.78B
GILD GILEAD SCIENCES INC 14.22 136.94B
VRTX VERTEX PHARMACEUTICALS INC N/A 115.95B
REGN REGENERON PHARMACEUTICALS 11.82 56.53B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 39.44B
ARGX ARGENX SE - ADR 100.08 35.14B
ONC BEONE MEDICINES LTD-ADR 6.74 28.50B
BNTX BIONTECH SE-ADR N/A 25.70B
NTRA NATERA INC N/A 22.56B
BIIB BIOGEN INC 8.56 19.85B
INSM INSMED INC N/A 16.56B

About HCWB

Company Profile

HCWB logo image HCW Biologics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Miramar, Florida and currently employs 36 full-time employees. The company went IPO on 2021-07-20. HCW Biologics Inc. is a clinical-stage biopharmaceutical company. The company is focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases, such as cancer, cardiovascular diseases, diabetes, neurodegenerative diseases, autoimmune diseases, as well as other conditions. The company has developed a Tissue factOr-Based fusion (TOBI) discovery platform to generate designer, novel multi-functional fusion molecules with immunotherapeutic properties. Its lead product candidates include HCW9218 and HCW9302. HCW9218 is a clinical-stage bifunctional molecule that is designed to impact senescence by reducing senescent cells. The firm is prepared to progress HCW9218 in Phase II clinical trials for non-oncology indications.HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes. Its other product candidates include HCW9201, HCW9206, HCW11-006, and others.

Company Info

HCW BIOLOGICS INC

2929 N Commerce Pkwy, Miramar, Fl 33025

Miramar FLORIDA US

Employees: 45

HCWB Company Website

HCWB Investor Relations

Phone: 19548422024

HCW BIOLOGICS INC / HCWB FAQ

What is the stock price of HCW BIOLOGICS INC today?

The current stock price of HCWB is 5.49 USD. The price decreased by -1.61% in the last trading session.


What is the ticker symbol for HCW BIOLOGICS INC stock?

The exchange symbol of HCW BIOLOGICS INC is HCWB and it is listed on the Nasdaq exchange.


On which exchange is HCWB stock listed?

HCWB stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for HCW BIOLOGICS INC stock?

7 analysts have analysed HCWB and the average price target is 35.7 USD. This implies a price increase of 550.27% is expected in the next year compared to the current price of 5.49. Check the HCW BIOLOGICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is HCW BIOLOGICS INC worth?

HCW BIOLOGICS INC (HCWB) has a market capitalization of 10.43M USD. This makes HCWB a Nano Cap stock.


How many employees does HCW BIOLOGICS INC have?

HCW BIOLOGICS INC (HCWB) currently has 45 employees.


What are the support and resistance levels for HCW BIOLOGICS INC (HCWB) stock?

HCW BIOLOGICS INC (HCWB) has a resistance level at 9.8. Check the full technical report for a detailed analysis of HCWB support and resistance levels.


Is HCW BIOLOGICS INC (HCWB) expected to grow?

The Revenue of HCW BIOLOGICS INC (HCWB) is expected to decline by -100% in the next year. Check the estimates tab for more information on the HCWB EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy HCW BIOLOGICS INC (HCWB) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does HCW BIOLOGICS INC (HCWB) stock pay dividends?

HCWB does not pay a dividend.


What is the Price/Earnings (PE) ratio of HCW BIOLOGICS INC (HCWB)?

HCW BIOLOGICS INC (HCWB) does not have a PE ratio as the earnings reported over the last twelve months were negative (-25.15).


What is the Short Interest ratio of HCW BIOLOGICS INC (HCWB) stock?

The outstanding short interest for HCW BIOLOGICS INC (HCWB) is 21.85% of its float. Check the ownership tab for more information on the HCWB short interest.


HCWB Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to HCWB. When comparing the yearly performance of all stocks, HCWB is a bad performer in the overall market: 99.07% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

HCWB Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to HCWB. Both the profitability and financial health of HCWB have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

HCWB Financial Highlights

Over the last trailing twelve months HCWB reported a non-GAAP Earnings per Share(EPS) of -25.15. The EPS increased by 16.61% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -94.12%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%75.47%
Sales Q2Q%-99.11%
EPS 1Y (TTM)16.61%
Revenue 1Y (TTM)-63.04%

HCWB Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to HCWB. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of 3.51% and a revenue growth -100% for HCWB


Ownership
Inst Owners7.02%
Ins Owners40.57%
Short Float %21.85%
Short Ratio0.33
Analysts
Analysts82.86
Price Target35.7 (550.27%)
EPS Next Y3.51%
Revenue Next Year-100%